JPWO2023282269A1 - - Google Patents
Info
- Publication number
- JPWO2023282269A1 JPWO2023282269A1 JP2023533152A JP2023533152A JPWO2023282269A1 JP WO2023282269 A1 JPWO2023282269 A1 JP WO2023282269A1 JP 2023533152 A JP2023533152 A JP 2023533152A JP 2023533152 A JP2023533152 A JP 2023533152A JP WO2023282269 A1 JPWO2023282269 A1 JP WO2023282269A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D341/00—Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021113378 | 2021-07-08 | ||
| PCT/JP2022/026755 WO2023282269A1 (ja) | 2021-07-08 | 2022-07-05 | パーキンソン病の予防又は治療薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023282269A1 true JPWO2023282269A1 (https=) | 2023-01-12 |
| JPWO2023282269A5 JPWO2023282269A5 (https=) | 2024-04-04 |
Family
ID=84801700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023533152A Pending JPWO2023282269A1 (https=) | 2021-07-08 | 2022-07-05 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240293359A1 (https=) |
| EP (1) | EP4342464A4 (https=) |
| JP (1) | JPWO2023282269A1 (https=) |
| CN (1) | CN117320709A (https=) |
| WO (1) | WO2023282269A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12552764B2 (en) | 2020-08-27 | 2026-02-17 | Kyowa Pharma Chemical Co., Ltd. | Trisulfide compound and clathrate thereof |
| TW202321270A (zh) * | 2021-09-09 | 2023-06-01 | 國立大學法人九州大學 | 使用三硫化合物之防止肝細胞增殖因子中之酪胺酸殘基之硝基化的方法 |
| WO2025070464A1 (ja) * | 2023-09-28 | 2025-04-03 | 協和ファーマケミカル株式会社 | トリスルフィド化合物を含有する医薬組成物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5668117A (en) * | 1991-02-22 | 1997-09-16 | Shapiro; Howard K. | Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments |
| WO2006043532A1 (ja) * | 2004-10-19 | 2006-04-27 | Ono Pharmaceutical Co., Ltd. | パーキンソン病治療剤 |
| WO2017177262A1 (en) * | 2016-04-11 | 2017-10-19 | University Of Canberra | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier |
| EP3560947B1 (en) | 2016-12-20 | 2022-08-24 | Kyowa Hakko Bio Co., Ltd. | Crystal of glutathione trisulfide dihydrate and method for producing same |
| CN111699023A (zh) * | 2017-12-07 | 2020-09-22 | C·杜克 | 线粒体靶向、mptp调节以及线粒体反应物质和/或线粒体反应脂质物质的还原 |
| CN111320603A (zh) * | 2018-12-13 | 2020-06-23 | 江苏同禾药业有限公司 | 一种硫辛酸工艺杂质的制备方法 |
| JP2022074166A (ja) * | 2019-01-30 | 2022-05-18 | 協和発酵バイオ株式会社 | ポリスルフィド化合物を含有する組成物 |
| JP2022166333A (ja) * | 2019-09-18 | 2022-11-02 | 国立大学法人 熊本大学 | 活性イオウ分子種生体内濃度上昇剤 |
| CN115087635B (zh) | 2020-03-31 | 2024-04-12 | 协和医药化工股份有限公司 | 三硫化物化合物或硒代三硫化物化合物的制造方法 |
| JP7842033B2 (ja) * | 2020-05-12 | 2026-04-07 | ザ ジェネラル ホスピタル コーポレイション | 神経保護におけるグルタチオントリスルフィド（ｇｓｓｓｇ） |
| US12552764B2 (en) | 2020-08-27 | 2026-02-17 | Kyowa Pharma Chemical Co., Ltd. | Trisulfide compound and clathrate thereof |
| JP7650279B2 (ja) | 2020-08-27 | 2025-03-24 | 協和ファーマケミカル株式会社 | トリスルフィド化合物 |
-
2022
- 2022-07-05 EP EP22837683.6A patent/EP4342464A4/en active Pending
- 2022-07-05 CN CN202280032414.5A patent/CN117320709A/zh active Pending
- 2022-07-05 US US18/572,109 patent/US20240293359A1/en active Pending
- 2022-07-05 WO PCT/JP2022/026755 patent/WO2023282269A1/ja not_active Ceased
- 2022-07-05 JP JP2023533152A patent/JPWO2023282269A1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4342464A4 (en) | 2025-06-04 |
| US20240293359A1 (en) | 2024-09-05 |
| CN117320709A (zh) | 2023-12-29 |
| WO2023282269A1 (ja) | 2023-01-12 |
| EP4342464A1 (en) | 2024-03-27 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231122 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250501 |